SEC Form 4 · accession 0001209191-15-033727
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John F Crowley
Officer — Chairman & CEO · Director
Period of report
Apr 10, 2015
Accepted (ET)
Apr 13, 2015 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 10, 2015 | M | 11,678 | $12.00 | A | 95,177 | D | |
| Common Stock | Apr 10, 2015 | S | 11,678 | $12.00 | D | 83,499 | D | |
| Common Stock | holding | — | — | — | 64,895 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) | $5.325 | Apr 10, 2015 | M | 11,678 | D | Feb 1, 2010 | Feb 28, 2016 | Common Stock | 11,678 | 0 | D |
Explanation of responses
- F1The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.
Remarks
The stock options exercised under this Rule 10b5-1 trading plan were due to expire on February 28, 2016. After this transaction, Mr. Crowley holds stock options for approximately 2 million shares of Amicus Therapeutics, Inc. common stock.